Loading...

Precipio, Inc.

PRPONASDAQ
Healthcare
Medical - Diagnostics & Research
$14.26
$-0.24(-1.66%)

Precipio, Inc. (PRPO) Financial Performance & Income Statement Overview

Review Precipio, Inc. (PRPO) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
5.05%
5.05%
Operating Income Growth
44.67%
44.67%
Net Income Growth
26.70%
26.70%
Operating Cash Flow Growth
112.33%
112.33%
Operating Margin
-12.72%
12.72%
Gross Margin
46.14%
46.14%
Net Profit Margin
-8.76%
8.76%
ROE
-15.00%
15.001%
ROIC
-18.09%
18.09%

Precipio, Inc. (PRPO) Income Statement & Financial Overview

Review Precipio, Inc. PRPO income statement with detailed quarterly and annual figures.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$4.26M$5.45M$5.21M$4.44M
Cost of Revenue$2.12M$2.80M$2.93M$3.02M
Gross Profit$2.14M$2.65M$2.28M$1.42M
Gross Profit Ratio$0.50$0.49$0.44$0.32
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$0.00$2.65M$0.00$2.63M
Operating Expenses$3.00M$2.98M$2.87M$2.63M
Total Costs & Expenses$5.12M$5.79M$5.81M$5.65M
Interest Income$0.00$0.00$0.00$0.00
Interest Expense-$25000.00$29000.00$29000.00$11000.00
Depreciation & Amortization$0.00$382000.00$381000.00$355000.00
EBITDA-$859000.00$46000.00-$216000.00-$854000.00
EBITDA Ratio-$0.20$0.008-$0.04-$0.19
Operating Income-$859000.00-$336000.00-$597000.00-$1.21M
Operating Income Ratio-$0.20-$0.06-$0.11-$0.27
Other Income/Expenses (Net)-$25000.00-$29000.00-$29000.00-$11000.00
Income Before Tax-$884000.00-$365000.00-$626000.00-$1.22M
Income Before Tax Ratio-$0.21-$0.07-$0.12-$0.27
Income Tax Expense$0.00$0.00$0.00$0.00
Net Income-$884000.00-$365000.00-$626000.00-$1.22M
Net Income Ratio-$0.21-$0.07-$0.12-$0.27
EPS-$0.59-$0.25-$0.42-$0.83
Diluted EPS-$0.59-$0.25-$0.42-$0.83
Weighted Avg Shares Outstanding$1.50M$1.47M$1.48M$1.46M
Weighted Avg Shares Outstanding (Diluted)$1.50M$1.47M$1.48M$1.46M

Financial performance has remained strong, with revenue growing from $4.44M in Q2 2024 to $4.26M in Q1 2025. Gross profit continued to perform well, with margins at 50% in the latest quarter. Operating income reached -$859000.00 in Q1 2025, holding a steady -20% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$859000.00. Net income dropped to -$884000.00, keeping EPS at -$0.59. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;